Works by Isaacs, Randi
Results: 9
A Phase IB multicentre dose-determination study of BHQ880 in combination with anti-myeloma therapy and zoledronic acid in patients with relapsed or refractory multiple myeloma and prior skeletal-related events.
- Published in:
- British Journal of Haematology, 2014, v. 167, n. 3, p. 366, doi. 10.1111/bjh.13056
- By:
- Publication type:
- Article
Morphologic and ultrastructural evidence for interleukin-6 induced platelet activation.
- Published in:
- American Journal of Hematology, 1995, v. 48, n. 2, p. 92, doi. 10.1002/ajh.2830480205
- By:
- Publication type:
- Article
Posaconazole for the Treatment of Azole-Refractory Oropharyngeal and Esophageal Candidiasis in Subjects with HIV Infection.
- Published in:
- Clinical Infectious Diseases, 2007, v. 44, n. 4, p. 607, doi. 10.1086/511039
- By:
- Publication type:
- Article
A Multicenter Randomized Trial Evaluating Posaconazole versus Fluconazole for the Treatment of Oropharyngeal Candidiasis in Subjects with HIV/AIDS.
- Published in:
- Clinical Infectious Diseases, 2006, v. 42, n. 8, p. 1179, doi. 10.1086/501457
- By:
- Publication type:
- Article
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma.
- Published in:
- Science Translational Medicine, 2017, v. 9, n. 399, p. 1, doi. 10.1126/scitranslmed.aaa0984
- By:
- Publication type:
- Article
B cell maturation antigen-specific CAR T cells are clinically active in multiple myeloma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Unexpected hepatotoxicity in a phase I study of TAS266, a novel tetravalent agonistic Nanobody® targeting the DR5 receptor.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Unexpected hepatotoxicity in a phase I study of TAS266, a novel tetravalent agonistic Nanobody targeting the DR5 receptor.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 5, p. 887, doi. 10.1007/s00280-015-2712-0
- By:
- Publication type:
- Article
Multivalent nanobodies targeting death receptor 5 elicit superior tumor cell killing through efficient caspase induction.
- Published in:
- mAbs, 2014, v. 6, n. 6, p. 1560, doi. 10.4161/19420862.2014.975099
- By:
- Publication type:
- Article